DeepMed Research

The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.hopkinsmedicine.org/kimmel_cancer_center

Clinical Trials

Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior

Phase 2

Terminated

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Cytarabine consolidation
Drug: Allogeneic transplant

First Posted Date: 2012-05-01

Last Posted Date: 2018-08-14

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 10

Registration Number: NCT01588951

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.

Phase 2

Terminated

Conditions: Carcinoma, Non-Small-Cell Lung
Lung Adenocarcinoma

Interventions: Drug: Paclitaxel
Drug: Carboplatin
Drug: Bevacizumab
Drug: Metformin

First Posted Date: 2012-04-17

Last Posted Date: 2018-12-19

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 25

Registration Number: NCT01578551

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins University SKCCC, Baltimore, Maryland, United States

A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma

Phase 1

Completed

Conditions: Virally Mediated Cancers and Liposarcoma
Solid Tumors

Interventions: Drug: oral 5-azacitidine in combination with romidepsin

First Posted Date: 2012-02-23

Last Posted Date: 2017-03-24

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 18

Registration Number: NCT01537744

Locations: 🇺🇸
Sidney Kimmel Cancer Center @ Johns Hopkins, Baltimore, Maryland, United States

Radiation and Androgen Ablation for Prostate Cancer

Phase 1

Active, not recruiting

Conditions: Adenocarcinoma of the Prostate

Interventions: Radiation: Radiation Therapy
Drug: Androgen Deprivation Therapy (ADT)

First Posted Date: 2012-01-25

Last Posted Date: 2024-06-07

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 105

Registration Number: NCT01517451

Locations: 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
Suburban Hospital, Bethesda, Maryland, United States
🇺🇸
Sibley Memorial Hospital, Washington, District of Columbia, United States

Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas

Phase 1

Terminated

Conditions: Astrocytoma
Glioma

Interventions: Drug: 5-Aminolevulinic Acid

First Posted Date: 2011-12-30

Last Posted Date: 2017-01-05

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 6

Registration Number: NCT01502605

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: 18F-DCFBC

First Posted Date: 2011-12-21

Last Posted Date: 2018-08-28

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 15

Registration Number: NCT01496157

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients

Phase 1

Terminated

Conditions: Head and Neck Cancer

Interventions: Biological: DNA Vaccine
Drug: Cyclophosphamide

First Posted Date: 2011-12-15

Last Posted Date: 2018-11-23

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 2

Registration Number: NCT01493154

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, Maryland, United States

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: temozolomide
Other: 3'-deoxy-3'-[18F]fluorothymidine
Other: pharmacological study
Drug: Mibefradil

First Posted Date: 2011-11-28

Last Posted Date: 2019-05-22

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 28

Registration Number: NCT01480050

Locations: 🇺🇸
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States

and more 4 locations

Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide

Not Applicable

Completed

Conditions: Glioblastoma Multiforme

Interventions: Radiation: Radiation
Drug: Chemotherapy

First Posted Date: 2011-11-23

Last Posted Date: 2019-06-13

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 33

Registration Number: NCT01478854

Locations: 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Pre-Prostatectomy Lovastatin on Prostate Cancer

Not Applicable

Terminated

Conditions: Prostate Cancer

Interventions: Drug: Lovastatin

First Posted Date: 2011-11-23

Last Posted Date: 2019-03-27

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 2

Registration Number: NCT01478828

Locations: 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy